机构：[1]Department of Endocrinology, Zhongda Hospital, Institute of Diabetes,School of Medicine, Southeast University, Nanjing, China[2]Department ofEndocrinology, Peking University People’s Hospital, Beijing, China[3]Department of Endocrinology, Zhengzhou University First Affiliated Hospital,Zhengzhou, China[4]Department of Endocrinology, Chongqing MedicalUniversity First Affiliated Hospital, Chongqing, China[5]BD DiabetesCare Medical Affairs, Franklin Lakes, New Jersey
第一作者机构：[1]Department of Endocrinology, Zhongda Hospital, Institute of Diabetes,School of Medicine, Southeast University, Nanjing, China
推荐引用方式(GB/T 7714)：
Xu Xiaohan,Sun Zilin,Ji Linong,et al.Prevalence and contributing risk factors of insulin-induced lipoatrophy among people with diabetes in China[J].DIABETES-METABOLISM RESEARCH AND REVIEWS.2019,35:
APA：
Xu, Xiaohan,Sun, Zilin,Ji, Linong,Qin, Guijun,Li, Qifu&Hirsch, Laurence J..(2019).Prevalence and contributing risk factors of insulin-induced lipoatrophy among people with diabetes in China.DIABETES-METABOLISM RESEARCH AND REVIEWS,35,
MLA：
Xu, Xiaohan,et al."Prevalence and contributing risk factors of insulin-induced lipoatrophy among people with diabetes in China".DIABETES-METABOLISM RESEARCH AND REVIEWS 35.(2019)
